121 related articles for article (PubMed ID: 7662136)
1. Serious silver sulphadiazine and mafenide acetate dermatitis.
McKenna SR; Latenser BA; Jones LM; Barrette RR; Sherman HF; Varcelotti JR
Burns; 1995 Jun; 21(4):310-2. PubMed ID: 7662136
[TBL] [Abstract][Full Text] [Related]
2. Allergic contact dermatitis to mafenide acetate: a case series and review of the literature.
Firoz EF; Firoz BF; Williams JF; Henning JS
J Drugs Dermatol; 2007 Aug; 6(8):825-8. PubMed ID: 17763614
[TBL] [Abstract][Full Text] [Related]
3. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
Rode H; de Wet PM; Davies MR; Cywes S
Prog Pediatr Surg; 1981; 14():189-208. PubMed ID: 7221007
[TBL] [Abstract][Full Text] [Related]
4. Allergic contact dermatitis to silver in a patient treated with silver sulphadiazine after a burn.
García AA; Rodríguez Martín AM; Serra Baldrich E; Manubens Mercade E; Puig Sanz L
J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):365-6. PubMed ID: 25338976
[No Abstract] [Full Text] [Related]
5. Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds.
Gray JH; Henry DA; Forbes M; Germann E; Roberts FJ; Snelling CF
Burns; 1991 Feb; 17(1):37-40. PubMed ID: 2031672
[TBL] [Abstract][Full Text] [Related]
6. Mafenide-induced pseudochondritis.
Perry AW; Gottlieb LJ; Krizek TJ; Parsons RW; Goodwin CW; Finkelstein JL; Madden MR
J Burn Care Rehabil; 1988; 9(2):145-7. PubMed ID: 2966158
[TBL] [Abstract][Full Text] [Related]
7. Five percent mafenide acetate solution in the treatment of thermal injuries.
Kucan JO; Smoot EC
J Burn Care Rehabil; 1993; 14(2 Pt 1):158-63. PubMed ID: 8501103
[TBL] [Abstract][Full Text] [Related]
8. Adverse reaction to sulphonamides in a burned patient--a case report.
Sawada Y
Burns Incl Therm Inj; 1985 Dec; 12(2):127-31. PubMed ID: 2936433
[TBL] [Abstract][Full Text] [Related]
9. Allergic contact dermatitis from topical mafenide.
Sanz de Galdeano C; Aguirre A; Oleaga JM; Goday J; Diaz Perez JL
Contact Dermatitis; 1993 Apr; 28(4):249. PubMed ID: 8508643
[No Abstract] [Full Text] [Related]
10. Topical silver sulphadiazine: side effects and urinary excretion.
Lockhart SP; Rushworth A; Azmy AA; Raine PA
Burns Incl Therm Inj; 1983 Sep; 10(1):9-12. PubMed ID: 6640389
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of maphenide and silver sulphadiazine.
Pegg SP; Ramsay K; Meldrum L; Laundy M
Scand J Plast Reconstr Surg; 1979; 13(1):95-101. PubMed ID: 451487
[TBL] [Abstract][Full Text] [Related]
12. Silver debate continue.
Hermans MH
J Wound Care; 2011 Jun; 20(6):286. PubMed ID: 21727878
[No Abstract] [Full Text] [Related]
13. Absorption, excretion and tissue distribution of silver sulphadiazine.
Sano S; Fujimori R; Takashima M; Itokawa Y
Burns Incl Therm Inj; 1982 Mar; 8(4):278-85. PubMed ID: 7066727
[TBL] [Abstract][Full Text] [Related]
14. Concomitant sensitization to enoxolone and mafenide in a topical medicament.
Fernández JC; Gamboa P; Jáuregui I; González G; Antépara I
Contact Dermatitis; 1992 Oct; 27(4):262. PubMed ID: 1451499
[No Abstract] [Full Text] [Related]
15. The side effects of silver sulfadiazine.
Fuller FW
J Burn Care Res; 2009; 30(3):464-70. PubMed ID: 19349889
[TBL] [Abstract][Full Text] [Related]
16. Leukopenia in acute thermal injury: evidence against topical silver sulfadiazine as the causative agent.
Thomson PD; Moore NP; Rice TL; Prasad JK
J Burn Care Rehabil; 1989; 10(5):418-20. PubMed ID: 2793919
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity to human leukocytes by topical antimicrobial agents used for burn care.
Zapata-Sirvent RL; Hansbrough JF
J Burn Care Rehabil; 1993; 14(2 Pt 1):132-40. PubMed ID: 8501099
[TBL] [Abstract][Full Text] [Related]
18. Topical silver sulphadiazine and profound neutropenia in a burned child.
Wilson P; George R; Raine P
Burns Incl Therm Inj; 1986 Apr; 12(4):295-6. PubMed ID: 3719408
[No Abstract] [Full Text] [Related]
19. Topical therapy for control of bacteria in the burn wound.
Moncrief JA
World J Surg; 1978 Mar; 2(2):151-65. PubMed ID: 676330
[No Abstract] [Full Text] [Related]
20. Systemic absorption of sulphadiazine, silver sulphadiazine and sodium sulphadiazine through human burn wounds.
Aoyama H; Yokoo K; Fujii K
Burns; 1990 Jun; 16(3):163-5. PubMed ID: 2383353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
